The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 10, 2012, Pages 2545-2547

  Dube L ^a   Caillon, J ^a   Jacqueline, C ^a   Bugnon, D ^a   Potel, G ^a   Asseray, N ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; NETILMICIN; TOBRAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTITIS; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; COMPUTER SIMULATION; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; EXPERIMENTAL STUDY; FEMALE; IN VIVO STUDY; NONHUMAN; OPTIMAL DRUG DOSE; PHARMACOKINETICS; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; TREATMENT DURATION;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECALIS; FEMALE; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; NETILMICIN; RABBITS; TIME FACTORS; TOBRAMYCIN;

EID: 84869125255     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1594-x     Document Type: Article

References (14)

1. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL; ESC Committee for Practice Guidelines (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369-2413
2. Lefort A, Arthur M, Garry L, Carbon C, Courvalin P, Fantin B (2000) Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo. Antimicrob Agents Chemother 44:2077-2080
3. Sullam PM, Täuber MG, Hackbarth CJ, Sande MA (1985) Antimicrobial activity of gentamicin in experimental enterococcal endocarditis. Antimicrob Agents Chemother 27:224-226
4. Dubé L, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Granry JC, Potel G, Bugnon D (2003) Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model. Antimicrob Agents Chemother 47:3663-3666
5. Falagas ME, Matthaiou DK, Bliziotis IA (2006) The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-Analysis of comparative trials. J Antimicrob Chemother 57:639-647
6. Comité de l'Antibiogramme de la Société Française de Microbiologie. Recommandations 2009. http://www.sfm- microbiologie. org/UserFiles/file/CASFM/casfm-2009-1.pdf
7. Perlman BB, Freedman LR (1971) Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J Bio Med 44:206-213
8. Bugnon D, Potel G, Caillon J, Baron D, Drugeon HB, Feigel P, Kergueris MF (1998) In vivo simulation of human pharmacokinetics in the rabbit. Bull Math Biol 60:545-567
9. Asseray N, Caillon J, Roux N, Jacqueline C, Bismuth R, Kergueris MF, Potel G, Bugnon D (2002) Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Antimicrob Agents Chemother 46:1591-1593
10. Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A (1996) Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother 40:173-178
11. Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A (2003) Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. J Antimicrob Chemother 52:514-517
12. López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A (2001) Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis. Antimicrob Agents Chemother 45:1387-1393
13. Lugo G, Castañeda-Hernández G (1997) Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis. Crit Care Med 25:806-811
14. Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA (2002) Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Intensive Care Med 28:936-942